Live Case from Columbia University: Lotus and Watchman Devices

 

Operators: Dr. Robert Sommer, Dr. Susheel Kodali.

Chairpersons: Martin Leon, José Eduardo Morais Rego Sousa.

Panelists: José Armando Mangione, Josep Rodés Cabau, Fabio Sândoli de Brito Jr., Dimytri Alexandre de Alvim Siqueira, Eberhard Grube, Henrique Barbosa Ribeiro, Hugo Francisco Londero.

More articles by this author

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

Rewatch our event “The Visible Heart Lab” on coronary bifurcations

You can now watch our event held in collaboration with Medtronic, titled "The Visible Heart Lab – Live Cases on DK Crush and Culotte." The...

Bringing More MIL / MINT to Light Through CLIMB Grants – Check out our educational event again

You can now relive our virtual event on "Bringing More MIL / MINT to Light Through CLIMB Grants", held last May 2 on our...

The Visible Heart Lab – Rewatch now our event on coronary bifurcations

You can now relive our virtual event on “The Visible Heart Lab” on Forks, held in conjunction with Medtronic. The event was held on April...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...